Gene Therapy Manufacturing

Development and Manufacturing Services

Forge provides integrated development and manufacturing services from research-grade production and process development through cGMP and commercial manufacturing. These capabilities are brought together under one roof at one of the world’s largest manufacturing facilities dedicated to AAV.

Research-Grade Manufacturing

Blaze research-grade AAV production at 1–40L is ideal for discovery work like material generation for proof-of-concept studies or assessing vector manufacturability. With a scalable process and Forge’s proprietary technologies, it gives early-stage developers confidence in a seamless path to cGMP.

Process Development

Forge takes a flexible approach to meet each program where it is, from comprehensive process development to our established platform with targeted, product-specific optimizations, or technology transfer of an existing process. Each path is designed to support performance, scalability, and cGMP readiness.

cGMP Manufacturing

Forge’s cGMP production—ranging from 50 to 5,000L—is designed for scalability, efficiency, and repeatable manufacturing success. Backed by deep technical expertise, the team leverages single-use technologies and optimized closed-system processes to produce larger batches with high throughput and minimal variability.

Analytical Development & Quality Control

At Forge, we offer 30+ in-house AAV assays, including potency, rcAAV, mass spectrometry, and more to accelerate characterization and release. The integrated QC and QA framework, supported by cGMP compliance and connected systems, ensures consistent, compliant quality manufacturing from start to finish.

Fill-Finish

Forge offers a range of fill-finish services to meet the needs of your program. We provide drug product fill options across semi-automated and automated operations, designed to accommodate varying batch sizes, container types, and fill volumes to meet your product requirements.

Supporting Services

Forge provides molecular development and regulatory expertise, from early development through cGMP and beyond, including construct manufacturability guidance, program strategy, agency interactions, and CMC/IMPD documentation.

Accelerate with the FUEL™ Platform

Forge’s FUEL™ platform provides an established foundation for AAV manufacturing, combining proprietary technologies and proven processes with product-specific optimization to improve productivity and recovery while maintaining product quality.

Proprietary Technologies

Our gene therapy proprietary technologies, including the Ignition™ Cell Line, pEMBR™ 2.0 Ad Helper Plasmid, and Modified Rep Caps, support more efficient AAV manufacturing.

Product-Specific Optimizations

We’ve mapped 50+ upstream and downstream studies to help optimize yield, purity, and efficiency

Proven Processes

With over 600 manufacturing batches completed to date across dozens of indications and every serotype, including novel, our platform manufacturing processes are well established and backed by extensive real-world experience

60+

Clients Supported Across All Stages

97%

Of Clients Use Our Technologies

600+

Batches Manufactured

35+

Indications That We Expertly Support

A Specialized Partner

As part of Aji Bio-Pharma, Forge brings a dedicated gene therapy manufacturing service built on specialized expertise, purpose-built infrastructure, and proprietary technologies to a network of specialized CDMOs and enabling technologies.

Backed by Global Scale

Forge’s dedicated gene therapy expertise is backed by Aji Bio-Pharma’s global resources and commitment to rigorous quality, operational excellence, sustainability, and a century-long legacy of scientific innovation.

Hot off the Forge

Forge You Path

Learn More at Forge Biologics

Let’s talk about how we can scale your AAV research today.